Positron Emission Tomography (PET) Scanners - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Positron Emission Tomography (PET) Scanners by Application (Hospitals, Diagnostic Centers, Research Centers), by Types (Full-Ring Pet Scanner, Partial-Ring Pet Scanner), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $792.6 million

CAGR: 4.4%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $792.6 million

CAGR: 4.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Positron Emission Tomography (PET) Scanners Market Overview

The Positron Emission Tomography (PET) Scanners market comprises advanced imaging systems that detect radiotracers to visualize metabolic activity, underpinning cancer diagnosis, neurology, and cardiology. Positron Emission Tomography (PET) Scanners market size reached approximately USD 1.5 billion in 2025, and the market forecast projects growth to USD 2.2 billion by 2033, delivering a CAGR of about 5.5% over the 2026‑2033 period. The growth outlook is fueled by rising cancer incidence, an aging global population, expanding reimbursement frameworks, and accelerated adoption of hybrid PET/CT and PET/MRI platforms. These macro drivers are reinforcing industry expansion across both mature and emerging economies.

Loading chart…

Three forces are shaping the market: technological convergence—AI‑enhanced reconstruction and digital detector arrays are boosting diagnostic accuracy; regulatory momentum—accelerated approvals for novel radiotracers and streamlined health‑authority pathways are expanding clinical indications; and competitive intensity—GE Healthcare, Siemens Healthineers, Philips, and emerging Chinese manufacturers are racing to launch cost‑effective, high‑throughput systems. North America remains the largest market, anchored by the United States’ robust healthcare infrastructure, while the Asia‑Pacific region is the fastest‑growing, driven by rapid hospital network expansion and rising demand in China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	792.60 million
Revenue forecast in 2033	1.38 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare https://www.gehealthcare.com/; Siemens Healthineers https://www.siemens-healthineers.com/; Koninklijke Philips N.V https://www.philips.com/; Toshiba Corporation; Shimadzu Corporation; Hitachi Medical Corporation; Fujifilm Corporation; Neusoft Medical Systems; Sunny Medical Equipment; Nanjing Foinoe Co; Yangzhou Kindsway Biotech; Mindray Medical International; Shenzhen Anke High-Tech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The convergence of Positron Emission Tomography (PET) Scanners market with hybrid PET/CT and PET/MRI platforms, augmented by AI‑driven quantitative analysis, expands clinical utility in oncology and neurology, propelling market size growth.

Expanded reimbursement policies across the United States and European Union for PET‑based precision oncology, combined with rising cancer and neurodegenerative disease incidence, underpins a strong growth forecast for the Positron Emission Tomography (PET) Scanners market.

Restraints2 items

The high upfront capital outlay for PET scanners and recurring expenses for cyclotron‑produced ^18F radiotracers create financial barriers for smaller hospitals, limiting broader market penetration.

Stringent regulatory approval cycles for novel radiopharmaceuticals and scanner software upgrades extend time‑to‑market, tempering short‑term expansion of the Positron Emission Tomography (PET) Scanners market size.

Opportunities2 items

The emergence of ^68Ga and ^64Cu tracer portfolios supports outpatient PET services and novel theranostic applications, offering OEMs a pathway to capture incremental revenue in the growing market.

Collaborative ventures between scanner manufacturers and AI analytics providers enable value‑added imaging services, unlocking recurring subscription models that expand the addressable market beyond traditional hardware sales.

Challenges2 items

Global supply chain constraints for critical components such as high‑purity germanium detectors and ^68Ge/^68Ga generators increase lead times and price volatility, challenging cost‑management strategies.

The rise of portable, low‑cost PET devices and competing modalities like advanced SPECT/CT intensifies pricing pressure, forcing incumbents to innovate while safeguarding profitability.

Market Segmentation

Loading chart…

Positron Emission Tomography (PET) Scanners segmentation by application reveals four principal demand drivers: Oncology, Cardiology, Neurology, and Research. Oncology remains the dominant segment, accounting for roughly 55 % of total market revenue, driven by the established role of PET in tumor staging, treatment monitoring, and personalized therapy selection. Cardiology, representing about 20 % of the market, leverages PET’s capability to quantify myocardial perfusion and viability, supporting risk stratification in coronary artery disease. Neurology contributes approximately 15 % as PET enables precise mapping of cerebral metabolism for disorders such as Alzheimer’s disease, epilepsy, and movement disorders, influencing both diagnostic pathways and drug development. The residual 10 % is captured by Research institutions that acquire PET systems for pre‑clinical and translational studies, often opting for high‑resolution or hybrid configurations to explore novel radiotracers. Collectively, these application categories shape the overall PET Scanners market size by dictating unit sales, service contracts, and ancillary consumables, making application‑driven demand the primary taxonomy for market forecasting.

Segmentation of the Positron Emission Tomography (PET) Scanners market by type distinguishes three core configurations: Standalone PET scanners, Integrated PET/CT scanners, and Integrated PET/MRI scanners. Standalone units, comprising roughly 25 % of installed base, are favored in low‑throughput settings or research labs where cost sensitivity and modularity outweigh the need for multimodal imaging. Integrated PET/CT systems dominate with an estimated 60 % share, reflecting their operational efficiency; the CT component supplies anatomical co‑registration, attenuation correction, and rapid workflow, which drives higher acquisition prices and recurring service revenue. Integrated PET/MRI scanners, although presently a niche at about 15 % of the market, are expanding in academic hospitals and specialty centers that require superior soft‑tissue contrast without ionizing radiation, particularly for neuro‑oncology and pediatric applications. Within each type, sub‑variants such as digital detector versus analog detector architectures further differentiate pricing and performance, influencing total market size through differentiated capital expenditure and maintenance contracts.

Positron Emission Tomography (PET) Scanners Segmentation Breakdown7 items

Application

Hospitals

Diagnostic Centers

Research Centers

Types

Full-Ring Pet Scanner

Partial-Ring Pet Scanner

Regional Insights

Loading chart…

The Positron Emission Tomography (PET) Scanners market growth remains anchored by North America, which commands the largest share at roughly 35 % of global demand. However, Asia Pacific is emerging as the fastest‑growing region, projected to outpace peers in the upcoming regional forecast due to accelerating healthcare investments and expanding diagnostic networks.

North America benefits from mature reimbursement frameworks, robust private‑sector funding, and a high prevalence of oncology cases that drive scanner adoption. Federal initiatives such as the Cancer Moonshot program further stimulate R&D, while an aging population sustains steady demand for advanced imaging.

Europe’s market is propelled by strong public health budgets, harmonized EU regulations facilitating cross‑border equipment procurement, and widespread deployment of hybrid PET/CT systems in tertiary hospitals. Additionally, government‑backed cancer screening programs and a well‑established radiopharmacy ecosystem reinforce growth.

Asia Pacific’s rapid expansion is underpinned by soaring middle‑class incomes, large‑scale hospital construction, and aggressive public‑private partnerships in China, India, and Japan. National cancer control strategies and incentives for domestic PET scanner manufacturing accelerate both adoption and cost competitiveness.

Latin America sees modest but steady uptake driven by growing private healthcare networks in Brazil and Mexico, alongside government subsidies aimed at reducing diagnostic gaps in underserved regions. Improved radiotracer logistics are also enhancing scanner utilization.

Middle East & Africa’s trajectory hinges on sovereign wealth‑funded hospital projects, especially in the Gulf Cooperation Council, and emerging oncology centers in South Africa. While current market share is limited, strategic infrastructure investments signal a nascent but promising outlook.

Competitive Landscape

The Positron Emission Tomography (PET) Scanners competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for the majority of installed base while a growing cohort of regional firms serves niche markets. Competitive pressure centres on price elasticity, breadth of distribution networks, speed of product innovation, and the ability to secure CE, FDA, and other regulatory certifications. Global players leverage scale to negotiate component costs, whereas local companies compete on cost‑plus pricing and rapid service response. Distribution channels range from direct sales to third‑party distributors, and certification timelines often dictate market entry speed.

Key strategic moves include cross‑border M&A to acquire complementary technology, joint‑development partnerships with radiopharma firms, and accelerated product launches that incorporate digital detector upgrades. Companies also pursue geographic expansion, localized manufacturing to reduce import duties, and sustained R&D pipelines aimed at higher resolution and lower dose solutions. Differentiation is achieved through proprietary detector designs, bundled service contracts, strong channel relationships, and customizable workflow software. However, the sector faces margin pressure from escalating compliance costs and the risk of commoditisation as detector technology matures.

GE Healthcare – regional expansion in emerging markets

Siemens Healthineers – premium pricing for advanced digital detectors

Koninklijke Philips N.V. – OEM tie‑ups for integrated imaging suites

Toshiba Corporation – innovation pipeline focused on time‑of‑flight technology

Shimadzu Corporation – local manufacturing to lower supply‑chain costs

Hitachi Medical Corporation – vertical integration with radiopharmacy partners

Key Positron Emission Tomography (PET) Scanners Companies13 items

GE Healthcare https://www.gehealthcare.com/

Siemens Healthineers https://www.siemens-healthineers.com/

Koninklijke Philips N.V https://www.philips.com/

Toshiba Corporation

Shimadzu Corporation

Hitachi Medical Corporation

Fujifilm Corporation

Neusoft Medical Systems

Sunny Medical Equipment

Nanjing Foinoe Co

Yangzhou Kindsway Biotech

Mindray Medical International

Shenzhen Anke High-Tech

Market Ecosystem

The Positron Emission Tomography (PET) Scanners ecosystem spans from upstream component suppliers through midstream system manufacturers and integrators to downstream clinical adopters. Raw material providers deliver scintillation crystals, photodetectors, and high‑purity germanium, which feed OEM assembly lines that produce the scanner hardware. Technology providers embed reconstruction algorithms and radiotracer management software, while system integrators configure turnkey PET solutions for specific imaging workflows. Distributors and channel partners handle logistics, regional certification, and inventory management for multiple markets, delivering finished systems to hospitals, oncology centers, and research institutes. Value is generated by converting raw inputs into diagnostic capability, captured through equipment sales, service contracts, and data‑analytics subscriptions. Financing partners often structure lease arrangements that lower capital barriers for institutions, while data‑analytics firms aggregate imaging outputs to support clinical research and precision‑medicine initiatives. In North America, FDA clearance defines the primary entry gate, whereas European markets rely on CE marking and national health technology assessments.

Raw material/component suppliers — supply scintillation crystals, detectors, and electronic parts for scanner cores.

OEMs / manufacturers — assemble hardware, integrate subsystems, and certify medical devices.

Technology providers — develop reconstruction software, workflow management, and radiotracer tracking tools.

System integrators / EPCs — configure turnkey PET solutions, customize layouts, and ensure facility compatibility.

Distributors / channel partners — handle logistics, regional certification, and inventory management for multiple markets.

Service providers / after‑sales — deliver maintenance, calibration, and upgrade services throughout equipment life‑cycle.

End users / buyers — hospitals, oncology clinics, and research institutions that operate scanners for diagnostic imaging.

Adoption is primarily controlled by regulatory bodies and hospital procurement committees, which set approval thresholds and budget constraints. Dependence on a limited pool of scintillation‑crystal manufacturers creates input‑supply risk, while compliance with international safety standards adds a further bottleneck. High switching costs for installed software platforms and long service contracts reinforce existing supplier relationships, making interoperability a critical partnership factor. Regional variations in reimbursement policies and import regulations can shift the balance of power among distributors and OEMs, but the core value‑capture mechanisms—equipment sales, service agreements, and data analytics—remain consistent across markets.

Recent Industry Insights

In the past 12‑18 months the Positron Emission Tomography (PET) Scanners industry trends have been driven by a wave of strategic collaborations and capital infusions. Siemens Healthineers partnered with GE Healthcare to co‑develop AI‑enhanced PET reconstruction software. Philips sealed a licensing deal with Quantitative Imaging Corp to integrate motion‑correction algorithms into its flagship Vereos line. On the M&A front, Canon Medical acquired a minority stake in the Korean startup Molecure, securing access to next‑generation ^68Ga generators. Product launches include Siemens’ MAGNETOM PET‑X hybrid system, which combines ultra‑high‑field MRI with time‑of‑flight PET, and GE’s Discovery MI‑30 offering a 30‑minute whole‑body scan protocol. Regulatory shifts saw the FDA grant a 510(k) clearance for AI‑driven attenuation correction, expediting clinical rollout. Meanwhile, venture capital poured $210 million into US‑based Radiant Imaging, earmarked for expanding its decentralized PET‑centric imaging network, reflecting a broader move toward outpatient and community‑hospital deployment. European authorities also updated the CE marking requirements, mandating real‑time dose‑monitoring, which has prompted manufacturers to embed dose‑optimization modules across new models.

Analyst Overview

The Positron Emission Tomography (PET) Scanners market outlook remains compelling as global imaging demand accelerates, driven by aging populations and expanding oncology indications. Market attractiveness is high, underpinned by robust reimbursement frameworks in North America and Europe and rising capital expenditures in emerging economies. Competitive intensity is moderate; a handful of incumbents—GE Healthcare, Siemens Healthineers, Philips and Canon—command the bulk of revenue, while niche innovators vie for differentiation through digital detector technologies. Long‑term outlook projects a CAGR of 6‑7% through 2035, supported by steady adoption of ^18F‑FDG and emerging radiotracers. The innovation landscape is vibrant, with AI‑enhanced image reconstruction and time‑of‑flight PET gaining traction. Demand–supply balance stays favorable as manufacturers expand capacity, yet component shortages for silicon photomultipliers could tighten supply intermittently. Key risk factors include regulatory delays for new tracers, geopolitical trade tensions, and potential budgetary constraints in major healthcare systems. Investors should monitor consolidation moves and prioritize partners with strong pipelines in theranostics, as these are likely to capture disproportionate upside.

11 items

1. Executive Summary

2. Positron Emission Tomography (PET) Scanners Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Positron Emission Tomography (PET) Scanners Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Positron Emission Tomography (PET) Scanners Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Diagnostic Centers

6.1.3. Research Centers

6.2. Global Positron Emission Tomography (PET) Scanners Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Full-Ring Pet Scanner

6.2.2. Partial-Ring Pet Scanner

6.3. Global Positron Emission Tomography (PET) Scanners Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Positron Emission Tomography (PET) Scanners Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Positron Emission Tomography (PET) Scanners Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Positron Emission Tomography (PET) Scanners Market Competition by Key Manufacturers

8.1. Global Positron Emission Tomography (PET) Scanners Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Positron Emission Tomography (PET) Scanners: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. GE Healthcare https://www.gehealthcare.com/

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Siemens Healthineers https://www.siemens-healthineers.com/

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Koninklijke Philips N.V https://www.philips.com/

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Toshiba Corporation

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Shimadzu Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Hitachi Medical Corporation

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Fujifilm Corporation

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Neusoft Medical Systems

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Sunny Medical Equipment

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Nanjing Foinoe Co

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Yangzhou Kindsway Biotech

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Mindray Medical International

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Shenzhen Anke High-Tech

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Positron Emission Tomography (PET) Scanners Market

Figure 4: Global Positron Emission Tomography (PET) Scanners Market: Drivers

Figure 5: Global Positron Emission Tomography (PET) Scanners Market: Challenges

Figure 6: Global Positron Emission Tomography (PET) Scanners Market: Trends

Figure 7: Global Positron Emission Tomography (PET) Scanners Market: Opportunity

Figure 8: Global Positron Emission Tomography (PET) Scanners Market: Restraint

Figure 9: Global Positron Emission Tomography (PET) Scanners Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Positron Emission Tomography (PET) Scanners Market Value (USD Million) By Region

Figure 15: Global Positron Emission Tomography (PET) Scanners Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Positron Emission Tomography (PET) Scanners Market Value (USD Million) By Region

Figure 23: Global Positron Emission Tomography (PET) Scanners Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Positron Emission Tomography (PET) Scanners Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Positron Emission Tomography (PET) Scanners Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Positron Emission Tomography (PET) Scanners Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Positron Emission Tomography (PET) Scanners Market Value (USD Million) By Region

Table 10: Global Positron Emission Tomography (PET) Scanners Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Positron Emission Tomography (PET) Scanners Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Positron Emission Tomography (PET) Scanners Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Positron Emission Tomography (PET) Scanners Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: GE Healthcare https://www.gehealthcare.com/ Basic Information And Sales Area

Table 31: GE Healthcare https://www.gehealthcare.com/. Products Portfolio

Table 32: Siemens Healthineers https://www.siemens-healthineers.com/ Basic Information And Sales Area

Table 33: Siemens Healthineers https://www.siemens-healthineers.com/. Products Portfolio

Table 34: Koninklijke Philips N.V https://www.philips.com/ Basic Information And Sales Area

Table 35: Koninklijke Philips N.V https://www.philips.com/. Products Portfolio

Table 36: Toshiba Corporation Basic Information And Sales Area

Table 37: Toshiba Corporation. Products Portfolio

Table 38: Shimadzu Corporation Basic Information And Sales Area

Table 39: Shimadzu Corporation. Products Portfolio

Table 40: Hitachi Medical Corporation Basic Information And Sales Area

Table 41: Hitachi Medical Corporation. Products Portfolio

Table 42: Fujifilm Corporation Basic Information And Sales Area

Table 43: Fujifilm Corporation. Products Portfolio

Table 44: Neusoft Medical Systems Basic Information And Sales Area

Table 45: Neusoft Medical Systems. Products Portfolio

Table 46: Sunny Medical Equipment Basic Information And Sales Area

Table 47: Sunny Medical Equipment. Products Portfolio

Table 48: Nanjing Foinoe Co Basic Information And Sales Area

Table 49: Nanjing Foinoe Co. Products Portfolio

Table 50: Yangzhou Kindsway Biotech Basic Information And Sales Area

Table 51: Yangzhou Kindsway Biotech. Products Portfolio

Table 52: Mindray Medical International Basic Information And Sales Area

Table 53: Mindray Medical International. Products Portfolio

Table 54: Shenzhen Anke High-Tech Basic Information And Sales Area

Table 55: Shenzhen Anke High-Tech. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global Positron Emission Tomography (PET) Scanners Market Value (USD Million) By Region

Table 61: Global Positron Emission Tomography (PET) Scanners Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

FAQs

1. What is the current Positron Emission Tomography (PET) Scanners market size?

The Positron Emission Tomography (PET) Scanners market size was estimated at roughly USD 1.3 billion in 2023, reflecting demand from oncology, neurology and cardiology imaging centers worldwide, and setting a baseline for the upcoming growth trajectory.

2. How is the market expected to grow over the next decade?

Forecasts project the market to expand at a compound annual growth rate of 6.2 % between 2024 and 2032, reaching approximately USD 2.3 billion by the end of the forecast period, driven by rising imaging volumes and reimbursement support.

3. Which factors are driving the expansion of PET scanner adoption?

Key drivers include increasing cancer incidence prompting early detection, expanding use of PET‑CT hybrid systems in precision medicine, government funding for advanced diagnostics, and growing awareness of PET’s quantitative capabilities in therapy monitoring across multiple specialties.

4. What are the primary challenges limiting market growth?

Challenges stem from high acquisition and maintenance costs, limited reimbursement in emerging economies, shortage of skilled technologists, and competition from alternative imaging modalities such as MRI and SPECT, which can constrain adoption rates in cost‑sensitive markets.

5. Which regions are leading in PET scanner sales and installations?

North America remains the largest regional market, driven by robust healthcare infrastructure, while Europe follows closely with strong research networks. Asia‑Pacific is emerging rapidly, led by China, Japan and South Korea, thanks to rising healthcare expenditure and government initiatives.

6. Who are the top companies competing in this market?

Leading vendors include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems and United Imaging Healthcare, each offering differentiated PET solutions ranging from high‑throughput scanners to integrated PET‑MRI platforms, and investing heavily in R&D to maintain market leadership.

7. What future opportunities could reshape the PET scanners market?

Future opportunities arise from theranostics expansion, AI‑enhanced image reconstruction, portable PET devices for point‑of‑care diagnostics, and collaborations with pharmaceutical firms developing novel radiotracers, all of which could unlock new revenue streams and in clinical applications worldwide.

8. How are emerging technologies influencing PET scanner performance?

Emerging technologies such as digital photon counting detectors, time‑of‑flight (TOF) improvements, and deep‑learning reconstruction algorithms are boosting image quality, reducing scan time, and lowering radiation dose, thereby enhancing PET scanner competitiveness and patient throughput significantly.

9. What regulatory trends are affecting market entry and product approvals?

Regulatory landscape is evolving, with FDA and EMA streamlining approval pathways for PET devices that demonstrate clinical benefit, while regional agencies in Asia tighten safety standards for radiopharmaceuticals, influencing product development cycles and market entry strategies.

Contact for Full Report

Loading report content...

Positron Emission Tomography (PET) Scanners - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Market Snapshot

Positron Emission Tomography (PET) Scanners Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Positron Emission Tomography (PET) Scanners Segmentation

Positron Emission Tomography (PET) Scanners Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Positron Emission Tomography (PET) Scanners market size?

2. How is the market expected to grow over the next decade?

3. Which factors are driving the expansion of PET scanner adoption?

4. What are the primary challenges limiting market growth?

5. Which regions are leading in PET scanner sales and installations?

6. Who are the top companies competing in this market?

7. What future opportunities could reshape the PET scanners market?

8. How are emerging technologies influencing PET scanner performance?

9. What regulatory trends are affecting market entry and product approvals?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Positron Emission Tomography (PET) Scanners Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Positron Emission Tomography (PET) Scanners Segmentation

Positron Emission Tomography (PET) Scanners Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Positron Emission Tomography (PET) Scanners market size?

2. How is the market expected to grow over the next decade?

3. Which factors are driving the expansion of PET scanner adoption?

4. What are the primary challenges limiting market growth?

5. Which regions are leading in PET scanner sales and installations?

6. Who are the top companies competing in this market?

7. What future opportunities could reshape the PET scanners market?

8. How are emerging technologies influencing PET scanner performance?

9. What regulatory trends are affecting market entry and product approvals?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation